pulseheadlines.com

Share

pulseheadlines.com

 •  August 4

The U.S. Food and Drug Administration (FDA) announced today its approval for a new drug to treat chronic hepatitis C, including patients with moderate or severe kidney disease and those who are on dialysis. The drug, Mavyret, is manufactured by AbbVie Inc. and is intended for people without cirrhosis or mild cirrhosis. The new drug was also...

pulseheadlines.com

 •  July 13

A new kind of cancer treatment received U.S. regulatory approval on Wednesday. The treatment uses genetically edited cells from a patient’s immune system to attack cancer and will be used to treat children with the most common type of leukemia. A Food and Drug Administration (FDA) advisory committee voted unanimously to recommend approval of the...

pulseheadlines.com

 •  May 27

According to a new investigation, Suramin could be the cure for autism. This century-old drug has been used to treat the sleeping sickness, but its use also showed improvements in the autism symptoms of five boys that participated in a small clinical trial. However, researchers say that more studies need to be done. The research was driven by...

pulseheadlines.com

 •  May 6

The U.S. Food and Drug Administration approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS) on Friday. The disease, also known as Lou Gehrig’s disease, affects and kills the nerve cells that control voluntary muscles. The National Institute of Neurological Disorders and Stroke (NINDS) says that voluntary functions...

pulseheadlines.com

 •  April 30

The U.S. Food and Drug Administration has just approved Brineura, the first medical treatment for the rare CLN2 disease, or what it’s known as Batten disease which affects mainly kids between 2 and 4 years old. This would be one of the most expensive treatments the FDA has approved, costing a total of $700,000 per year Brineura is an enzyme...